loading

Policies

Journal Policies

Plagiarism policy

Open Access Policy

Publication ethics and malpractice statement

Peer Review Policy

Correction, Retraction and Withdrawal Policy

Copy Right and Licensing Policy

Plagiarism policy

Biosciences, Biotechnology Research Asia follows a strong plagiarism policy. It ensures that none of the part of manuscript is plagiarized from other sources and proper reference is provided for all contents extracted from other sources.

All the papers submitted have to pass through an initial screening and will be checked through the Advanced Plagiarism Detection Software (CrossCheck by iThenticate)

CrossCheck

Go to Top

Open Access Policy

OAThis is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

Go to Top

Publication ethics and malpractice statement

Biosciences, Biotechnology Research Asia’s Publication Ethics and Publication Malpractice Statement is based, in large part, on the guidelines and standards developed by the Committee on Publication Ethics (COPE). The relevant duties and expectations of authors, reviewers, and editors of the journal are set out below.

  1. Responsibilities of Authors
    By submitting a manuscript to Biosciences, Biotechnology Research Asia, the author(s) warrant that the manuscript is their own, original work and that it has neither been published previously nor is currently being considered for publication elsewhere. They also warrant that the sources of any ideas and/or words in the manuscript that are not their own have been properly attributed through appropriate citations and/or quotes.An author should not normally publish manuscripts describing essentially the same research in multiple journals or publication venues. Such redundant publication is generally considered to constitute unethical publishing behavior, and if discovered may result in a manuscript under consideration being rejected, or a published article being retracted.Authors of manuscripts reporting on original research should present an accurate account of the work performed, accompanied by an objective discussion of its significance. Underlying data should be represented accurately in the manuscript. The manuscript should contain sufficient detail and references to permit others to replicate the work. The fabrication of results and the making of fraudulent or knowingly inaccurate statements constitute unethical behavior and may be cause for rejection or retraction of a manuscript or published article.Where the manuscript reports on commercial software, hardware, or other products, authors must include a declaration at the beginning of the manuscript in which they must either state that no conflict of interest exists or describe the nature of any potential conflict. All sources of financial support for the research should also be disclosed in the manuscript.The author(s) of a manuscript agree that if the manuscript is accepted for publication in Biosciences, Biotechnology Research Asia, the published article will be copyrighted using a Creative Commons “Attribution-Non Commercial-Share Alike” license. This license allows the author(s) to retain the copyright, but also allows others to freely copy, distribute, and display the copyrighted work, and derivative works based upon it, under certain specified conditions.Authors are responsible for obtaining written permission to include any images or artwork for which they do not hold copyright in their articles, or to adapt any such images or artwork for inclusion in their articles. The copyright holder must be made explicitly aware that the image(s) or artwork will be made freely available online as part of the article under a Creative Commons “Attribution-Non Commercial-Share Alike” license.The authors’ names should be listed on the article in order of their contribution to the article, and all authors take responsibility for their own contributions. Only those individuals who have made a substantive contribution should be listed as authors; those whose contributions are indirect or marginal (e.g., colleagues or supervisors who have reviewed drafts of the work or provided proofreading assistance, and heads of research institutes/centers/labs) should be named in an “Acknowledgments” section at the end of the article, immediately preceding the Reference List. The corresponding author must ensure that all appropriate co-authors and no inappropriate co-authors are included on the article, and that all listed co-authors have seen and approved the final version of the article and agreed to its publication.Where an author discovers a significant error or inaccuracy in an article of his/hers that has been published in Biosciences, Biotechnology Research Asia, he/she has an obligation to promptly notify the editors and cooperate with them to correct the article or retract it as appropriate.
  2. Responsibilities of Reviewers
    Biosciences, Biotechnology Research Asia’s reviewers perform work for the journal on a volunteer basis. Given that most of these individuals are in full-time employment, their reviewing activities for Biosciences, Biotechnology Research Asia must, by necessity, not be their top priority. Reviewers are free to decline invitations to review particular manuscripts at their discretion, for example, if their current employment workload and/or other commitments make it prohibitive for them to complete a review in a timely fashion and to do justice to the task in the available timeframe. They should also not accept manuscript review assignments for which they feel unqualified.Reviewers who have accepted manuscript assignments are normally expected to submit their reviews within three weeks. They should recuse themselves from the assignment if it becomes apparent to them at any stage that they do not possess the required expertise to perform the review, or that they may have a potential conflict of interest in performing the review (e.g., one resulting from competitive, collaborative, or other relationships or connections with any of the authors, institutions, or companies associated with the manuscript).Privileged information or ideas obtained by reviewers through the peer review process must be kept confidential and not used for personal advantage. Any manuscripts received for review must be treated as confidential documents, and must not be shown to or discussed with others except as authorized by the Biosciences, Biotechnology Research Asia Editor.When conducting their reviews, reviewers are asked to do so as objectively as possible, refraining from engaging in personal criticism of the author(s). They are encouraged to express their views clearly, explaining and justifying all recommendations made. They should always attempt to provide detailed and constructive feedback to assist the author(s) in improving their work, even if the manuscript is, in their opinion, not publishable.Reviewers should identify in their reviews relevant published work that has not been cited by the author(s), together with any instances in which proper attribution of sources has not been provided. They should call to the responsible editor’s attention any major resemblances between a manuscript under consideration and other published articles or papers of which they are aware, as well as any concerns they might have in relation to the ethical acceptability of the research reported in the manuscript.
  3. Responsibilities of Editors
    The Biosciences, Biotechnology Research Asia Editor has ultimate responsibility for deciding if a manuscript submitted to Biosciences, Biotechnology Research Asia should be published, and in doing so is guided by the journal’s policies as determined by the Biosciences, Biotechnology Research Asia editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism. The Editor may consult with the Associate Editor and other members of the editorial team, as well as with reviewers, in making publication decisions.The editors will evaluate manuscripts for their intellectual content without regard to the race, color, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or political philosophy of the author(s). They will not disclose any information about a manuscript under consideration to anyone other than the author(s), reviewers and potential reviewers, and in some instances the Biosciences, Biotechnology Research Asia editorial board members, as appropriate. Additionally, the editors will make every effort to ensure the integrity of the blind review process by not revealing the identity of the author(s) of a manuscript to the reviewers of that manuscript, and vice versa.When evaluating a manuscript for publication, in addition to considering standard criteria pertaining to the rigor of the manuscript, the quality of its presentation, and its contribution to humanity’s stock of knowledge, the editors will also seek evidence that ethical harms have been minimized in the conduct of the reported research. They will question whether the benefits outweigh the harms in the particular study’s case. Since Biosciences, Biotechnology Research Asiawelcomes the submission of manuscripts from any country, it is necessary to recognize that laws and regulations regarding research ethics and ethical approval vary worldwide. As such, the editors may need to seek clarification in this regard with the author(s) and request that they supply a letter from the relevant institutional ethics committee or board that approved the research.The editors will be guided by CORE’s Guidelines for Retracting Articles when considering retracting, issuing an expressions of concern about, and issuing corrections pertaining to articles that have been published in Biosciences, Biotechnology Research Asia. They are committed to working closely with research organizations and institutions in line with CORE’s advice on Cooperation between Research Institutions and Journals on Research Integrity Cases.

Go to Top

Peer Review Policy

The review process is an important aspect of the publication process of an article. It helps an editor in making decision on an article and also enables the author to improve the manuscript. Academic Journals operates a double blind review process.

Author(s) identity is removed from the manuscript and shielded from the reviewers during the review process. The reviewer is left with only the manuscript without any information that might enable him/her uncovers the identity of the author(s). Information removed includes the author(s) name, address/affiliation, country, phone/fax and email. Any information in the Acknowledgement and Declaration of Conflict of Interest that may lead to the uncovering of the identity of the author is also removed from the manuscript prior to sending it to reviewers.
Manuscripts are assigned to members of the editorial board of the journal or other qualified reviewers. The review process is done using the Manuscript Management System. Reviewers make one of the following recommendations:

  • Accept unconditionally
  • Accept conditionally
  • Reject in current form
  • Reject unconditionally
  • A Review Certificate is issued to reviewers after the review of the manuscript.

Go to Top

Correction, Retraction and Withdrawal Policy

  1. Corrections
    Corrections are published if the publication record is seriously affected with regard to the accuracy of published information. Corrections are published in the subsequent issue under Corrections and addendum.
  2. Retractions
    Retractions are done when the main conclusion of the paper is seriously undermined.Readers should first contact the authors of the original paper and then write to the journal, including copies of the correspondence with the authors. The editors will consult reviewers for their comments. The article will be retracted in cases such as multiple submission, plagiarism or fraudulent use of data.
    Biosciences, Biotechnology Research Asia’s Retraction policy is based, in large part, on the guidelines and standards developed by the Committee on Publication Ethics (COPE). Please see https://publicationethics.org/files/retraction%20guidelines.pdf
  3. Withdrawal Policy
    Articles can be withdrawn by either by the authors or the publishers. The article can withdraw any time before it is formally published online in its final form with complete information about volume, issue, page numbers, doi and article ID. If the authors request withdrawal of an article, a signed statement from the authors will be required to be submitted to the Editorial Office before an article can be withdrawn. If an article is found to violate the ethical publishing guidelines of the journal such as duplicate publication, plagiarism, fraudulent use of data, multiple submission or bogus claims of authorship, the article will be withdrawn by the publisher. In such case the article content will be removed from the HTML and PDF version of the Early View article and replaced by a note that the article has been withdrawn.

Go to Top

Copy Right and Licensing Policy

Copyright

The author(s) reserve(s) all proprietary rights such as patent rights and the right to use all or part of the article in future works of their own such as lectures, press releases, and reviews of textbooks. In the case of republication of the whole, part, or parts thereof, in periodicals or reprint publications by a third party, written permission must be obtained from the Editor‐in‐Chief Biosciences, Biotechnology Research Asia journal.

Copyright form can be downloaded at: Copyright Form

This form duly completed and signed should be submitted online while submitting manuscript.

Licensing Policy

As open access journal Biosciences, Biotechnology Research Asia  Journal follows the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Go to Top